Skip to main content
DCGO
NASDAQ Industrial Applications And Services

DocGo Raises 2026 Revenue Guidance Amid Strong Virtual Care Demand, Reports Mixed Q1 Results

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Healthcare Facility Stocks · Healthcare
Sentiment info
Neutral
Importance info
8
Price
$0.623
Mkt Cap
$58.477M
52W Low
$0.491
52W High
$1.93
52W Position info
27% above low
Off High info
68% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

DCGO sits 27% above its 52-week low of $0.491.

Summary

DocGo Inc. reported mixed first-quarter results with continued net losses but significantly raised its full-year 2026 revenue guidance, driven by strong demand for virtual care services.


Key Events · Earnings and Guidance · DCGO

  • Raised 2026 Revenue Guidance

    Full-year 2026 revenue guidance increased to $300-$315 million, up from prior guidance of $290-$310 million, driven by strong demand for virtual care services.

  • Mixed Q1 Financials

    Q1 2026 total revenue was $75.6 million (down from $96.0 million year-over-year due to migrant program wind-down), but core revenue (excluding migrant programs) grew 19.3%. Net loss widened to ($16.7) million from ($11.1) million year-over-year.

  • Continued Unprofitability & Cash Burn

    The company reported negative adjusted EBITDA of ($10.2) million and saw cash and cash equivalents decline to $59.9 million from $68.3 million in the prior quarter.

  • Strategic Context

    This positive revenue outlook comes as the company is exploring strategic alternatives and seeking shareholder approval for a reverse stock split to address its "going concern" warning and Nasdaq compliance issues.


Analysis · DCGO · Industrial Applications And Services

This filing provides a crucial update on DocGo's financial health, following previous disclosures of a "going concern" warning and a proposed reverse stock split. While the company continues to report net losses and negative adjusted EBITDA, the substantial increase in full-year revenue guidance, particularly from its core mobile health and virtual care segments, offers a positive signal. This improved outlook for core business growth could be vital as the company explores strategic alternatives and seeks to regain Nasdaq compliance.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, DCGO was trading at $0.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $58.5M. The 52-week trading range was $0.49 to $1.93. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

DCGO - Latest Insights

DCGO
Nov 13, 2026, 5:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.2057
Real-time Price: $0.181 info
Change: -$0.0247 (-12%) info
Market Cap: $16.987M info
DCGO
Nov 09, 2026, 4:37 PM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $0.2351
Real-time Price: $0.181 info
Change: -$0.0541 (-23%) info
Market Cap: $16.987M info
DCGO
Nov 09, 2026, 4:06 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.2469
Real-time Price: $0.181 info
Change: -$0.0659 (-27%) info
Market Cap: $16.987M info
DCGO
Nov 09, 2026, 4:05 PM EST
Source: BusinessWire
Importance Score:
8
Price at Filing: $0.2516
Real-time Price: $0.181 info
Change: -$0.0706 (-28%) info
Market Cap: $16.987M info
DCGO
Oct 05, 2026, 6:32 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.3632
Real-time Price: $0.181 info
Change: -$0.1822 (-50%) info
Market Cap: $16.987M info